Bioactive Surgical Sealants With Therapeutic Matrix-Remodeling Functions

Abstract

Bioactive surgical sealants have evolved from passive hemostatic agents to advanced biomaterials capable of therapeutic matrix-remodeling. These sealants not only provide mechanical closure but also actively participate in tissue healing, regulate local biological processes, and modulate cellular responses. This review synthesizes recent evidence on the development, mechanism of action, clinical applications, and future directions of bioactive surgical sealants with matrix-remodeling capabilities, offering a comprehensive resource for healthcare professionals seeking to integrate these innovations into surgical practice.

Introduction

Surgical sealants are critical adjuncts in modern operative procedures, providing hemostasis, tissue adhesion, and enhanced wound closure. Traditional sealants, while effective as barriers, often lack the ability to support active tissue regeneration or modulate the healing microenvironment. The emergence of bioactive surgical sealants with matrix-remodeling properties marks a paradigm shift, offering therapeutic potential beyond simple closure. These next-generation materials are engineered to interact with host tissues, promote cellular infiltration, and drive remodeling processes that underpin successful and functional repair. This article examines the scientific basis, clinical relevance, and practical applications of bioactive sealants designed for therapeutic matrix remodeling.

Epidemiology / Disease Burden

The incidence of surgical complications such as anastomotic leakage, fistula formation, and poor wound healing remains significant across multiple surgical specialties. Postoperative leaks occur in up to 10% of gastrointestinal surgeries, while seroma and hematoma formation complicate plastic and oncological procedures. In cardiovascular and thoracic surgeries, suture line bleeding and inadequate tissue integration continue to challenge outcomes. These complications are associated with increased morbidity, prolonged hospitalization, and substantial healthcare costs. As the number of complex surgical procedures rises globally, the demand for advanced sealant technologies capable of improving healing and reducing complications is increasing. Bioactive sealants with matrix-modulating functions address an unmet clinical need for improved surgical outcomes and reduced postoperative morbidity.

Pathophysiology

Effective tissue repair requires a balance between hemostasis, inflammation, proliferation, and remodeling. Traditional sealants act primarily as physical barriers, lacking the ability to influence local biological processes. In contrast, bioactive surgical sealants are designed to integrate with the extracellular matrix (ECM), facilitating cell migration, angiogenesis, and deposition of new matrix components. Key mechanisms include controlled release of bioactive molecules, modulation of matrix metalloproteinases (MMPs), and provision of scaffolding that mimics native ECM architecture. By orchestrating these processes, bioactive sealants support functional tissue regeneration and reduce the risk of fibrosis, chronic inflammation, and dehiscence. The therapeutic modulation of matrix remodeling is particularly relevant in tissues with limited regenerative capacity or where complex tissue interfaces exist.

Risk Factors

Patient factors such as advanced age, diabetes mellitus, immunosuppression, malnutrition, and smoking increase susceptibility to poor wound healing and postoperative complications. Surgical factors, including high-tension closures, devascularized tissue, and contaminated fields, further elevate risk. In these contexts, standard sealants may be insufficient, prompting the need for bioactive alternatives that can actively counteract adverse microenvironments. Recognizing and stratifying these risk factors is essential for selecting patients who may derive the greatest benefit from bioactive, matrix-remodeling sealants.

Clinical Features

Bioactive surgical sealants are characterized by their capacity to adhere to wet tissue surfaces, maintain flexibility, and degrade in a controlled manner compatible with tissue healing. Clinically, their application is associated with reduced leakage rates, enhanced hemostasis, and improved tissue integration. Unlike passive sealants, bioactive formulations can be tailored to release growth factors, recruit progenitor cells, and modulate inflammation, resulting in robust and functionally superior tissue repair. Surgeons may observe accelerated wound closure, decreased seroma or hematoma formation, and improved cosmetic and functional results in procedures utilizing these advanced materials.

Diagnosis

While the primary indication for surgical sealants is typically evident intraoperatively, patient selection for bioactive matrix-remodeling sealants requires assessment of wound environment, tissue quality, and individual risk factors. Preoperative imaging, laboratory markers of healing capacity, and intraoperative assessment of tissue perfusion can guide the decision to employ advanced bioactive sealants. Postoperative monitoring for signs of leakage, infection, or abnormal healing remains essential, as does histopathological evaluation in research settings to assess tissue integration and remodeling outcomes.

Treatment & Management

Bioactive surgical sealants are applied as adjuncts to conventional suturing or stapling techniques. Their use is particularly advantageous in high-risk anastomoses, vascular repairs, and reconstructive procedures where enhanced healing is desired. Application techniques vary by product formulation, ranging from sprayable hydrogels to moldable putties and adhesive sheets. Intraoperative protocols emphasize achieving hemostasis, minimizing contamination, and ensuring optimal sealant-tissue contact. Postoperative management includes monitoring for allergic reactions, infection, and sealant degradation, while facilitating physiologic wound remodeling through supportive care and rehabilitation as indicated.

Recent Advances / Emerging Therapies

Recent innovations include the integration of cell-derived exosomes, synthetic peptides, and gene-activated matrices into sealant formulations. Advances in biomimetic design allow for tunable degradation rates and targeted delivery of therapeutic agents, such as vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-β). Hybrid sealants that combine natural polymers (e.g., fibrin, gelatin) with synthetic scaffolds (e.g., polyethylene glycol, polyurethane) optimize both biocompatibility and mechanical strength. Emerging evidence supports the use of sealants with immunomodulatory properties, capable of reducing chronic inflammation and promoting regenerative healing in complex wounds. Ongoing clinical trials are evaluating next-generation sealants for applications in oncologic, cardiovascular, and minimally invasive surgery.

Guideline Recommendations

Current guidelines from surgical societies advocate for the selective use of bioactive sealants in high-risk patients and procedures associated with elevated leakage or dehiscence risk. Recommendations emphasize individualized patient assessment, appropriate product selection, and adherence to manufacturer instructions for optimal outcomes. Ongoing surveillance of safety and efficacy, as well as participation in registries and clinical trials, is encouraged to inform future guideline updates and refine best practices.

Conclusion

Bioactive surgical sealants with therapeutic matrix-remodeling functions represent a significant advancement in the field of surgical adjuncts, offering both mechanical and biological support for tissue healing. Their ability to modulate the local wound environment, promote regenerative processes, and reduce postoperative complications positions them as valuable tools in modern surgery. Continued research, multidisciplinary collaboration, and adherence to evidence-based protocols will be essential to fully realize the potential of these innovative biomaterials in improving surgical outcomes and patient care.